ABBY OLIVE: Open Payments
NPI 1689001596 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 14 payments from 8 companies in 2025. Trend: 2023 $99 · 2024 $279 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Inspire Medical Systems, Inc. | 3 | $70 |
| GENZYME CORPORATION | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: DUPIXENT, INSPIRE, TAKHZYRO, VOQUEZNA, TEZSPIRE, MOUNJARO.
Industry payments across AL — which companies pay providers there.
